ArticleScientific reports2026
Prolonged expiratory time constant and risk of moderate-to-severe exacerbations in stable COPD.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spirometry provides limited insight into small airway dysfunction in COPD, and evaluation of physiologic parameters such as the expiratory time constant (Tc) may offer complementary information for risk assessment. This retrospective cohort study included 1479 patients with COPD from two tertiary hospitals who underwent baseline chest computed tomography and post-bronchodilator spirometry between 2014 and 2023, with at least five years of follow-up. The Tc was computed from volume-time curves via standardized image analysis. The primary outcome was moderate-to-severe exacerbation. Subgroup analyses were conducted based on symptom severity, airflow limitation, emphysema extent, and airway wall thickness. A prolonged Tc was independently associated with an increased risk of moderate-to-severe exacerbations (adjusted hazard ratio, 1.188; 95% confidence interval, 1.028–1.373). This association was particularly evident in dyspneic patients and was more pronounced among those without a prior history of frequent exacerbations. Consistent patterns of association were observed across subgroups characterized by increased airway wall thickness, preserved diffusing capacity, and lower emphysema burden, corresponding to airway-predominant features. A threshold of 1.14 s was identified, above which the risk of exacerbation was significantly elevated. The Tc may improve individualized risk stratification by identifying patients with COPD who are at increased risk of exacerbations, even in the absence of prior exacerbation history or before the development of advanced parenchymal destruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.